| Line Item | 2023-04-29 | Y/Y |
|---|---|---|
| Revenue | $184.2M | +73.0% |
| Cost of Revenue | $78.0M | +83.7% |
| Gross Profit | $106.2M | +65.9% |
| R&D Expense | $76.8M | +60.1% |
| SG&A Expense | $48.2M | +38.2% |
| Operating Income | -$21.2M | +3.3% |
| Pre-tax Income | -$17.9M | +19.4% |
| Income Tax | -$1.4M | -3594.6% |
| Net Income | -$16.5M |
| Line Item | 2023-04-29 | Y/Y |
|---|---|---|
| Cash & Equivalents | $108.6M | -58.1% |
| Short-term Investments | $109.2M | — |
| Accounts Receivable | $49.5M | +67.8% |
| Inventory | $46.0M | +68.4% |
| Current Assets | $328.2M | -1.2% |
| Total Assets | $397.3M | +5.7% |
| Current Liabilities | $31.0M | +17.1% |
| Line Item | 2023-04-29 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$24.6M | +20.2% |
| Capital Expenditures | $21.7M | +23.5% |
| Investing Cash Flow | -$130.9M | -644.8% |
| Financing Cash Flow | $4.9M | -97.6% |
| Free Cash Flow | -$46.3M | +4.3% |
| +25.4% |
| EPS (Basic) | -$0.11 | +56.0% |
| EPS (Diluted) | -$0.11 | +56.0% |
| Total Liabilities |
| $49.7M |
| +19.6% |
| Stockholders' Equity | $347.6M | +4.0% |